C1q receptors: Regulating specific functions of phagocytic cells

Immunobiology

Volumn 199, Issue 2, 1998, Pages 250-264

  Tenner, Andrea J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CELL RECEPTOR; COMPLEMENT COMPONENT C1Q; COMPLEMENT RECEPTOR; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR; GLYCOPROTEIN; LECTIN; LUNG SURFACTANT; MANNOSE BINDING PROTEIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; SUPEROXIDE;

AMINO ACID SEQUENCE; BONE MARROW CELL; CONTROLLED STUDY; DNA SEQUENCE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR CLONING; NEUTROPHIL; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; THROMBOCYTE;

EID: 0031692665     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80031-4     Document Type: Article

References (70)

1. REID, K. B. M. 1983. Protein involved in the activation and control of the two pathways of human complement. Biochem. Soc. Trans. 11: 1.
2. THIEL, S., and K. B. M. REID. 1989. Structures and function associated with the group ot mammalian lectins containing collagen-like sequences. FEBS Letters 250: 78.
3. COOPER, N. R. 1985. The Classical Complement Pathway: Activation and Regulation of the First Complement Component. Advances in Immunology 37: 151.
4. GEWURZ, H., S. C. YING, H. JIANG, and T. F. LINT. 1993. Nonimmune activation of the classical complement pathway. Behring. Inst. Mitt. 93: 138.
5. JIANG, H., D. BURDICK, C. G. GLABE, C. W. COTMAN, and A. J. TENNER. 1994. β-amyloid activates complement by binding to a specific region of the collagen-like domain ot the C1q A chain. J. Immunol. 152: 5050.
6. CUATRECASAS, P., and M. D. HOLLENBERG. 1976. Membrane Receptors and Hormone Action. In Advances in Protein Chemistry. Academic Press, p. 251.
7. JENNE, D. E., B. LOWIN, M. C. PEITSCH, A. BOTTCHER, G. SCHMITZ, and J. TSCHOPP. 1991. Clusterin (Complement Lysin Inhibitor) Forms a High Density Lipoprotein Complex with Apolipoprotein A-I in Human Plasma. J. Biol. Chem. 266: 11030.
8. TAGA, T., M. HIBI, Y. HIRATA, K. YAMASAKI, K. YASUKAWA, T. MATSUDA, T. HIRANO, and T. KISHIMOTO. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58: 573.
9. KIRSCHFINK, M., L. BLASE, S. ENGELMANN, and R. SCHWARTZ-ALBIEZ. 1979. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1. J. Immunol. 158: 1324.
10. GHEBREHIWET, B., B. LIM, E. I. B. PEERSCHKE, A. C. WILLIS, and K. B. M. REID. 1994. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular «heads» of C1q. J. Exp. Med. 179: 1809.
11. DEDIO, J., and W. MULLER-ESTERL. 1996. Kininogen binding protein p33/gC1qR is localized in the vesicular fraction of endothelial cells. FEBS Lett. 399: 255.
12. VAN DEN BERG, R. H., F. PRINS, M. C. FABER-KROL, N. J. LYNCH, W. SCHWAEBLE, L. A. VAN ES, and M. R. DAHA. 1997. Intracellular localization of the human receptor for the globular domains of C1q. J. Immunol. 158: 3909.
13. PEERSCHKE, E. I. B., K. B. M. REID, and B. GHEBREHIWET. 1994. Identification of a novel 33-kDa C1q-binding site on human blood platelets. J. Immunol. 152: 5896.
14. KLICKSTEIN, L. B., S. F. BARBASHOV, T. LIU, R. M. JACK, and A. NICHOLSON-WELLER. 1997. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 7: 345.
15. BOBAK, D. A., T. G. GAITHER, M. M. FRANK, and A. J. TENNER. 1987. Modulation of FcR Function by complement: Subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J. Immunol. 138: 1150.
16. BOBAK, D. A., M. M. FRANK, and A. J. TENNER. 1988. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes. Eur. J. Immunol. 18: 2001.
17. OHKURO, M., K. KOBAYASHI, K. TAKAHASHI, and S. NAGASAWA. 1994. Effect of C1q on the processing of immune complexes by human neutrophils. Immunology 83: 507.
18. TENNER, A. J. 1993. Functional aspects of the C1q receptors. Behring Inst. Mitt. 93: 241.
19. GUAN, E., W. H. BURGESS, S. L. ROBINSON, E. B. GOODMAN, K. J. MCTIGUE, and A. J. TENNER. 1991. Phagocytic cell molecules that bind the collagen-like region of C1q: involvement in the C1q-mediated enhancement of phagocytosis. J. Biol. Chem. 266: 20345.
20. GUAN, E., S. L. ROBINSON, E. B. GODDMAN, and A. J. TENNER. 1994. Cell surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis. J. Immunol. 152: 4005.
21. p, the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 6: 119.
22. GEERTSMA, M. F., P. H. NIBBERING, H. P. HAAGSMAN, M. R. DAHA, and R. VAN FURTH. 1994. Binding of surfactant protein A to C1q receptors mediates phagocytosis of Staphylococcus aureus by monocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 267: L578.
23. GAYNOR, C. D., F. X. MCCORMACK, D. R. VOELKER, S. E. MCGOWAN, and L. S. SCHLESINGER. 1995. Pulmonary Surfactant Protein A Mediates Enhanced Phagocytosis of Mycobacterium tuberculosis by a Direct Interaction with Human Macrophages. J. Immunol. 155: 5343.
24. TINO, M. J., and J. R. WRIGHT. 1996. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 270: L677.
25. WRIGHT, J. R. 1997. Immunomodulatory functions of surfactant. Physiol. Rev. 77: 931.
26. TENNER, A. J., S. L. ROBINSON, J. BORCHELT, and J. R. WRIGHT. 1989. Human Pulmonary Surfactant protein (SP-A), a Protein Structurally Homologous to C1q, Can Enhance FcR- and CR1-mediated Phagocytosis. J. Biol. Chem. 264: 13923.
27. TENNER, A. J., S. L. ROBINSON, and R. A. B. EZEKOWITZ. 1995. Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M(r) component of the C1q receptor. Immunity. 3: 485.
28. EZEKOWITZ, R. A. B. 1991. Ante-antibody Immunity. Curr. Biol. 1: 60.
29. TURNER, M. W. 1996. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunology Today 17: 532.
30. RUIZ S., and A. J. TENNER. 1996. C1q and pulmonary surfactant protein A (SPA) trigger enhanced phagocytic capacity with identical kinetics and via the same 126,000 Mr cell surface C1q receptor. Mol. Immunol. 33: 65. (Abstract)
31. SOELL, M., E. LETT, F. HOLVECK, M. SCHOLLER, D. WACHSMANN, and J.-P. KLEIN. 1995. Activation of Human Monocytes by Streptococcal Rhamnose Glucose Polymers is Mediated by CD14 Antigen, and Mannan Binding Protein Inhibits TNF-α Release. J. Immunol. 154: 851.
32. BROWN, E. J., J. F. BOHNSACK, and H. D. GRESHAM. 1988. Mechanism of Inhibition of Immunoglobulin G-mediated Phagocytosis by Monoclonal Antibodies that Recognize the Mac-1 Antigen. J. Clin. Invest. 81: 365.
33. CHRONEOS, Z. C., R. ABDOLRASULNIA, J. A. WHITSETT, W. R. RICE, and V. L. SHEPHERD. 1996. Purification of a cell-surface receptor for Surfactant Protein A. J. Biol. Chem. 271: 16375.
34. HOLMSKOV, U., P. LAWSON, B. TEISNER, I. TORNOE, A. C. WILLIS, C. MORGAN, C. KOCH, and K. B. M. REID. 1997. Isolation and characterization of a new member of the scavenger receptor superfamily, Glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J. Biol. Chem. 272: 13743.
35. VESANEN M., M. WESSMAN, M. SALMINEN, and A. VAHERI. 1992. Activation of integrated human immunodeficiency virus type 1 in human neuroblastoma cells by the cytokines tumour necrosis factor alpha and interleukin-6. J. Gen. Virol. 73: 1753.
36. MCINTOSH, J. C., S. MERVIN-BLAKE, E. CONNER, and J. R. WRIGHT. 1996. Surfactant Protein-A protects growing cells and reduces tumor necrosis factor-α activity from lipopolysaccharide-stimulated macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 271: L310.
37. POUTSLAKA, D., M. MENGOZZI, E. VANNIER, B. SINHA, and C. A. DINARELLO. 1993. Cross-linking of the beta-glucan receptor on human monocytes results in Interleukin-1 receptor antagonist but not Interleukin-1 production. Blood 12: 3695.
38. BABINEAU, T. J., P. MARCELLO, W. SWAILS, A. KENLER, B. BISTRIAN, and R. A. FORSE. 1994. Randomized Phase I/II trial of a macrophage-specific immunomodulator (PGG-Glucan) in high-risk surgical patients. Ann. Surg. 5: 601.
39. ADAMS, D. S., S. C. PERO, J. B. PETRO, R. NATHANS, W. M. MACKIN, and E. WAKSHULL. 1997. PGG-Glucan activates NF-κB-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line. J. Leuk. Biol. 62: 865.
40. CHAKA, W., A. F. VERHEUL, V. V. VAISHNAV, R. CHERNIAK, J. SCHARRINGA, J. VERHOEF, H. SNIPPE, and A. I. HOEPELMAN. 1997. Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J. Immuno. 159: 2979.
41. KREMLEV, S. G., and D. S. PHELPS. 1994. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am. J. Physiol. Lung Mol. Cell. Biol. 11: L712.
42. p, the C1q Receptor that enhances Phagocytosis, is detected specifically in human cells of myeloid lineage, endothehal cells and platelets. J. Immunol. 160: 1929.
43. ANDREWS, B. s., M. SHADFORTH, P. CUNNINGHAM, and J. S. DAVIS, IV. 1981. Demonstration of a C1q Receptor on the Surface of Human Endothelial Cells. J. Immunol. 127: 1075.
44. HESS, K. L., K. S. R. S. TUDOR, J. D. JOHNSON, F. OSATI-ASHTIANI, D. S. ASKEW, and J. M. COOK-MILLS. 1997. Human and murine high endothelial venule cells phagocytose apoptotic leukocytes. Exp. Cell. Res. 236: 404.
45. BOWNESS, P. K A. DAVIES, P. J. NORSWORTHY, P. ATHANASSIOU, J. TAYLOR-WIEDEMANN, L. K. BORYSIEWICZ, P. A. R. MEYER, and M. J. WALPORT. 1994. Hereditary C1q deficiency and systemic lupus erythematosus. Q. J. Med. 87: 455.
46. WISNIESKI, J. J., and G. B. NAFF. 1989. Serum IgG Antibodies to C1q In Hypocomplementemic Urticarial Vasculitis Syndrome. Arthritis Rheum. 32: 1119.
47. TENNER, A. J., and N. R. COOPER. 1982. Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component. J. Immunol. 128: 2547.
48. HAMADA, A., J. YOUNG, R. A. CHMIELEWSKI, and B. M. GREENE. 1988. C1q Enhancement of Antibody-dependent Granulocyte-mediated Killing of Nonphagocytosable Targets In Vitro. J. Clin. Invest. 82: 945.
49. GOODMAN, E. B., and A. J. TENNER. 1992. Signal transduction mechanisms of C1q-mediated superoxide production: Evidence for the involvement of temporally distinct stauosporine insensitive and sensitive pathways. J. Immunol. 148: 3920.
50. GOODMAN, E. B., D. C. ANDERSON, and A. J. TENNER. 1995. C1q triggers neutrophil superoxide production by a unique CD18-dependent mechanism. J. Leuk. Biol. 58: 168.
51. RUIZ, S., A. H. HENSCHEN-EDMAN, and A. J. TENNER. 1995. Localization of the site on the complement component C1q required for the stimulation of neutrophil superoxide production. J. Biol. Chem. 270: 30627.
52. RUIZ, S., A. H. HENSCHEN-EDMAN, and A. J. TENNER. 1996. Identification of a region of the C1q C chain that is critical for the stimulation of neutrophil superoxide production by C1q. Mol. Immunol. 33: 38. (Abstract)
53. BOBAK, D. A., R. G. WASHBURN, and M. M. FRANK. 1988. C1q enhances the phagocytosis of cryptococcus neoformans blastospores by human monocytes. J. Immunol. 141: 592.
54. RIMOLDI, M. T., A. J. TENNER, D. A. BOBAK, and K. A. JOINER. 1989. Complement Component C1q Enhances Invasion of Human Mononuclear Phagocytes and Fibroblasts by Trypanosoma cruzi Trypomastigotes. J. Clin. Invest. 84: 1982.
55. ALVAREZ-DOMINGUEZ, C-. E-CARRASCO-MARIN, and F. LEYVA-COBIAN. 1993. Role of complement component C1q in phagocytosis of Listeria monocytogenes by murine macrophage-like cell lines. Infect. Immun. 61: 3664.
56. RYAN, U. S., D. R. SCHULTZ, J. D. GOODWIN, J. M. VANN. M. P. SELVARAJ, and M. A. HART. 1989. Role of C1q in Phagocytosis of Salmonella minnesota by Pulmonary Endothehal Cells. Infection and Immunity 57: 1356.
57. VAN DEN DOBBELSTEEN, M. E. A., F. J. VAN DER WOUDE, W. E. M. SCHROEIJERS, N. KLARMOHAMAD, L. A. VAN ES, and M. R. DAHA. 1993. C1q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells. J. Immunol. 151: 4315.
58. LOZADA, C., R. I. LEVIN, M. HUIE, R. HIRSCHBORN, D. NAIME, M. WHITLOW, P. A. RECHT, B. GOLDEN, and B. N. CRONSTEIN. 1995. Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc. Natl. Acad. Sci. USA 92: 8378.
59. DAHA, M. R., A. M. M. MILTENBURG, P. S. HIEMSZTRA, N. KLAR-MOHAMAD, L. A. VAN Es, and V. W. M. VAN HINSBERGH. 1988. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro. Eur. J. Immunol. 18: 783.
60. LEU, R. W., A. ZHOU, J. A. RUMMAGE, M. J. KENNEDY, and B. J. SHANNON. 1989. Exogenous C1q Reconstitutes resident But Not Inflammatory Mouse Peritoneal Macrophages for Fc Receptor-Dependent Cellular Cytotoxicity and Phagocytosis. J. Immunol. 143: 3250.
61. LEU, R. W., A. ZHOU, M. J. KENNEDY, and B. J. SHANNON. 1991. Exogenous C1q reconstitutes a secondary deficiency of C5-deficient AKR mouse macrophages for FcR-dependent cellular cytotoxicity and phagocytosis. J. Immunol. 146: 1233.
62. JIANG, H., C. A. STEWART, S. Y. TAN, D. J. FAST, J. A. RUMMAGE, and R. W. LEU. 1996. Transfection of L929 cells with complement subcomponent C1q B-chain antisense cDNA inhibits tumor necrosis factor-α binding to mediate cytotoxicity and nitric oxide generation. Cell. Immunol. 167: 293.
63. SHINGU, M., K. YOSHIOKA, M. NOBUNAGA, and T. MOTOMATU. 1989. C1q binding to human vascular smooth muscle cells mediates immune complex deposition and superoxide generation. Inflammation 13: 5: 561.
64. HAMADE, A., and B. M. GREENE. 1987. C1q enhancement of IgG-Dependent EosmophilMediated Killing of Schistosomula in Vitro. J. lmmunol. 138: 1240.
65. 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity. J. Exp. Med. 178: 579.
66. YOUNG, K. R., J. L. AMBRUS, Jr., A. MALBRAN, A. S. FAUCI, and A. J. TENNER. 1991. Complement Subcomponent C1q stimulates immunoglobulin production by human B lymphocytes. J. Immunol. 146: 3356.
67. DAHA, M. R., N. KLAR, R. HOEKZEMA, and L. A. VAN ES. 1990. enhanced Ig Production by Human Peripheral Lymphocytes Induced by Aggregated C1q. J. Immunol. 144: 1227.
68. 2+ In mouse Fibroblasts. J. Immunol. 141: 3177.
69. KOROTZER, T. I., J. A. CLAGETT, W. P. KOLB, and R. C. PAGE. 1980. Complement-Dependent Induction of DNA Synthesis and proliferation of Human Diploid Fibroblasts. J. Cell. Physiol. 105: 503.
70. SATO, T., M. G. A. VAN DIXHOORN, E. HEEMSKERK, L. A. VAN ES, and M. R. DAHA. 1997. C1q, a subunit of the first component of complement, enhances antibody-mediated apoptosis of cultured rat glomerular mesangial cells. Clin. exp. Immunol. 109: 510.